These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Evaluation of the use of prophylactic cranial irradiation in small cell lung cancer. Patel S, Macdonald OK, Suntharalingam M. Cancer; 2009 Feb 15; 115(4):842-50. PubMed ID: 19117355 [Abstract] [Full Text] [Related]
6. Surgical resection of limited disease small cell lung cancer in the new era of platinum chemotherapy: Its time has come. Brock MV, Hooker CM, Syphard JE, Westra W, Xu L, Alberg AJ, Mason D, Baylin SB, Herman JG, Yung RC, Brahmer J, Rudin CM, Ettinger DS, Yang SC. J Thorac Cardiovasc Surg; 2005 Jan 15; 129(1):64-72. PubMed ID: 15632826 [Abstract] [Full Text] [Related]
7. TNM stage is the most important determinant of survival in metachronous lung cancer. Lee BE, Port JL, Stiles BM, Saunders J, Paul S, Lee PC, Altorki N. Ann Thorac Surg; 2009 Oct 15; 88(4):1100-5. PubMed ID: 19766788 [Abstract] [Full Text] [Related]
14. Prognosis of 6644 resected non-small cell lung cancers in Japan: a Japanese lung cancer registry study. Goya T, Asamura H, Yoshimura H, Kato H, Shimokata K, Tsuchiya R, Sohara Y, Miya T, Miyaoka E, Japanese Joint Committee of Lung Cancer Registry. Lung Cancer; 2005 Nov 15; 50(2):227-34. PubMed ID: 16061304 [Abstract] [Full Text] [Related]
15. [Lung cancer: new staging system and prognosis]. Li C, Zhang R. Zhonghua Wai Ke Za Zhi; 2000 Mar 15; 38(3):189-91. PubMed ID: 11832024 [Abstract] [Full Text] [Related]
16. [Overall long-term survival in lung cancer analyzed in 610 unselected patients]. Sánchez de Cos Escuín J, Disdier Vicente C, Corral Peñafiel J, Riesco Miranda JA, Sojo González MA, Masa Jiménez JF. Arch Bronconeumol; 2004 Jun 15; 40(6):268-74. PubMed ID: 15161593 [Abstract] [Full Text] [Related]
19. The surgical treatment of lung cancer: a retrospective analysis of 2004 cases. Zhang D, Zhang R, Cheng G. Chin Med J (Engl); 1999 Jan 15; 112(1):25-8. PubMed ID: 11593634 [Abstract] [Full Text] [Related]
20. Trimodal therapy for histologically proven N2/3 non-small cell lung cancer: mid-term results and indicators for survival. Steger V, Walles T, Kosan B, Walker T, Kyriss T, Veit S, Dippon J, Friedel G. Ann Thorac Surg; 2009 Jun 15; 87(6):1676-83. PubMed ID: 19463576 [Abstract] [Full Text] [Related] Page: [Next] [New Search]